Are PBMs Unjustly Profiting from 340B Drug Pricing Program?
- The Community Oncology Alliance (COA) has raised concerns that the high volume of contract pharmacies participating in the 340B drug pricing program allows pharmacy benefit managers (PBMs) to profit from the savings instead of directing savings toward underserved patients. In an amicus brief filed with the US Court of Appeals for the Seventh...
